FAS exposed excessive prices for preventive-and-immune drug
The third stage of comparative analysis of drug prices exposed pricing violations for 7 medicines in Russia
FAS completed the third stage of comparative analysis of drug prices in Russia and other countries. In particular, prices were checked for preventive-and-immune drugs under the national calendar of preventive vaccination.
Deputy Head of FAS Department for Control over Social Sphere and Trade, Nadezhda Sharavsksya sated: “FAS has analyzed price data from 42 countries and found that seven drug positions when prices in Russia exceed the lowest [rice in some reference countries for Russia”.
The list of immune-biological drugs for immunoprophylaxis under the national calendar of preventive vaccination includes 21 International Non-Proprietary Names or 106 drug positions from various manufacturers registered in the Russian Federation in particular packaging.
FAS analyzed prices for drug circulating in Russia was performed to execute the order of the President of the Russian Federation.